References
- Hersh EM, Bodey GP, Nies BA, Freireich EJ. Cause of death in acute leukemia: a ten year study on 414 patients from 1954–1963. JAMA 1965;193:99–103.
- Han T, Stutzman L, Cohen E, Kim V. Effect of platelet transfusion on hemorrhage in patients with acute leukemia. An autopsy study. Cancer 1966;19:1937–42.
- Freireich EJ, Kilman A, Gaydos LA, et al. Response to repeated platelet transfusion from the same donor. Ann Int Med 1963;59:277–87.
- Lee EJ. Indications for platelet transfusion therapy. In: Clinical decisions in platelet therapy. Kurtz SA, Brubaker DB, eds. Bethesda, MD: American Association of Blood Banks, 1992:19–30.
- Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 1962;266:905–9.
- Belt RJ, Leite C, Haas CD, Stephens RL. Incidence of hemorrhagic complications in patients with cancer. JAMA 1978;239:2571–4.
- Dutcher JP, Schiffer CA, Aisner J, et al. Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumor. Cancer 1984;67:13–22.
- Beutler E. Platelet transfusions: the 20,000 μL trigger. Blood 1993;81:1411–3.
- Slichter SJ, Harker LA. Thrombocytopenia: mechanisms and management of defects in platelet production. Clin Hematol 1978;7:523–40.
- Alvarado J, Djerassi I, Farber S. Transfusion of fresh, concentrated platelets to children with acute leukemia. J Ped 1965;67:13–22.
- Djerassi I, Farber S, Evans AE. Transfusion of fresh platelet concentrates to patients with secondary thrombocytopenia. N Engl J Med 1963;268:221–6.
- Pisciotto PT, Benson K, Hume H, et al. Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients. Transfusion 1995;35:498–502.
- Gmur J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia. Lancet 1991;338:1223–6.
- Strauss RA. Clinical perspectives of platelet transfusions: defining the optimal dose. J Clinical Apheresis 1995;10:124–7.
- Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985;56:1105–9.
- Norol F, Duedari N, Kuentz M, et al. Comparison of different doses of platelet transfusion (abstract). Blood 1995;86 (suppl):353a.
- Herman JH, Klumpp TR, Christman RA, et al. The effect of platelet dose on the outcome of prophylactic platelet transfusion (abstract). Transfusion 1995;35(suppl):46S.
- Daly PA, Schiffer CA, Aisner J, Wiemik P. Platelet transfusion therapy: 1-hour post-transfusion increments are valuable in predicting the need for HLA initial preparation. JAMA 1980;243:435–8.
- Hogge DE, Dutcher JP, Aisner JP, et al. Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion. Am J Hematol 1983;14:363–9.
- Kickler TS, Braine HG, Ness PM. The predictive value of crossmatching platelet transfusion for alloimmunized patients. Transfusion 1985;25:385–90.